Cerebrovascular Accident (CVA)
14
4
5
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 14 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
43%
3 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 7 completed trials
Clinical Trials (14)
RESPARK - Brain Q for Chronic Stroke
Investigating Central Contributions to Fatigue Using Non-invasive Brain Stimulation
rTMS Plus CCFES-mediated Functional Task Practice for Severe Stroke
Q Therapeutic System for Chronic Stroke Recovery
Effectiveness of Enhanced External Counterpulsation for Post-acute Stroke Patients
Determinants of the Effectiveness of Robot-assisted Hand Movement Training
Strokecopilot: A Precision Medicine Tool in the Stroke Emergency
The Influence of tDCS on the Arm and Hand Function in Stroke Patients
Transcutaneous Vagus Nerve Stimulation (tVNS) and Robotic Training to Improve Arm Function After Stroke
Upper Limb Task-Oriented Rehabilitation With Robotic Exoskeleton for Hemiparetic Stroke Patients
The Role of Trans-spinal Direct Current Stimulation (tsDCS) in Treating Patients With Hand Spasticity After Stroke
Evaluating the Indego Exoskeleton for Persons With Hemiplegia Due to CVA
Mirror Box Therapy for Upper Limb Function With Stroke
Managing Dysexecutive Syndrome (DS): CIHR 2011-2014